Aberrant Calcium Signaling in Astrocytes Inhibits Neuronal Excitability in a Human Down Syndrome Stem Cell Model

SUMMARY Down syndrome (DS) is a genetic disorder that causes cognitive impairment. The staggering effects associated with an extra copy of human chromosome 21 (HSA21) complicates mechanistic understanding of DS pathophysiology. We examined the neuron-astrocyte interplay in a fully recapitulated HSA21 trisomy cellular model differentiated from DS-patient-derived induced pluripotent stem cells (iPSCs). By combining calcium imaging with genetic approaches, we discovered the functional defects of DS astroglia and their effects on neuronal excitability. Compared with control isogenic astroglia, DS astroglia exhibited more-frequent spontaneous calcium fluctuations, which reduced the excitability of co-cultured neurons. Furthermore, suppressed neuronal activity could be rescued by abolishing astrocytic spontaneous calcium activity either chemically by blocking adenosine-mediated signaling or genetically by knockdown of inositol triphosphate (IP3) receptors or S100B, a calcium binding protein coded on HSA21. Our results suggest a mechanism by which DS alters the function of astrocytes, which subsequently disturbs neuronal excitability.

[1]  S. Itohara,et al.  Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Reeves,et al.  The use of mouse models to understand and improve cognitive deficits in Down syndrome , 2011, Disease Models & Mechanisms.

[3]  Loredano Pollegioni,et al.  Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Orkin,et al.  A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome , 2012, Science Translational Medicine.

[5]  S. Lipton,et al.  Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction via modulation of glutamate receptor recycling in Down syndrome , 2013, Nature Medicine.

[6]  T. Adair.  Growth regulation of the vascular system: an emerging role for adenosine. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  D. Attwell,et al.  Astrocyte calcium signaling: the third wave , 2016, Nature Neuroscience.

[8]  M. C. Angulo,et al.  Glutamate Released from Glial Cells Synchronizes Neuronal Activity in the Hippocampus , 2004, The Journal of Neuroscience.

[9]  Lin Yao,et al.  Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons , 2018, Stem cell reports.

[10]  O. Manzoni,et al.  Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a , 2014, The Journal of Neuroscience.

[11]  S. Gandhi,et al.  Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase , 2010, The Journal of Biological Chemistry.

[12]  B. Khakh,et al.  Astrocyte calcium signaling: from observations to functions and the challenges therein. , 2015, Cold Spring Harbor perspectives in biology.

[13]  K. Eggan,et al.  Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. , 2008, Cell stem cell.

[14]  R. Robitaille,et al.  An astrocyte-dependent mechanism for neuronal rhythmogenesis , 2015, Nature Neuroscience.

[15]  A. Contestabile,et al.  Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome , 2015, Nature Medicine.

[16]  T. Takano,et al.  Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo , 2006, Nature Neuroscience.

[17]  J. Coyle,et al.  The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis , 2016, Trends in Neurosciences.

[18]  C. Tang,et al.  Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome. , 2018, Free radical biology & medicine.

[19]  Marius Wernig,et al.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.

[20]  Ben A. Barres,et al.  Looks Can Be Deceiving: Reconsidering the Evidence for Gliotransmission , 2014, Neuron.

[21]  I. Kola,et al.  ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. , 2003, Human molecular genetics.

[22]  S. Koizumi.  Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes , 2010, The FEBS journal.

[23]  Marina Schmid,et al.  The Third Wave , 2016 .

[24]  G. Turrigiano.  Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. , 2012, Cold Spring Harbor perspectives in biology.

[25]  P. Yarowsky,et al.  Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome , 2003, Journal of neuroscience research.

[26]  M. Dierssen.  Down syndrome: the brain in trisomic mode , 2012, Nature Reviews Neuroscience.

[27]  C. Chen,et al.  Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells , 2014, Nature Communications.

[28]  S. Barger,et al.  Disulfide-linked S100β dimers and signal transduction , 1992 .

[29]  H. Nam,et al.  Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders. , 2012, Alcoholism, clinical and experimental research.

[30]  Xiong Cao,et al.  Astrocyte-derived ATP modulates depressive-like behaviors , 2013, Nature Medicine.

[31]  Yan Ao,et al.  Astrocyte scar formation aids central nervous system axon regeneration , 2016, Nature.

[32]  E. Newman,et al.  Propagation of Intercellular Calcium Waves in Retinal Astrocytes and Müller Cells , 2001, The Journal of Neuroscience.

[33]  S. Barger,et al.  Disulfide-linked S100 beta dimers and signal transduction. , 1992, Biochimica et biophysica acta.

[34]  R. Hallock,et al.  The Role of Astrocytes in the Regulation of Synaptic Plasticity and Memory Formation , 2013, Neural plasticity.

[35]  Hee-Sup Shin,et al.  Channel-Mediated Tonic GABA Release from Glia , 2010, Science.

[36]  B. Yankner,et al.  Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.

[37]  D. Geschwind,et al.  Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.

[38]  J. Busciglio,et al.  A Role for Thrombospondin-1 Deficits in Astrocyte-Mediated Spine and Synaptic Pathology in Down's Syndrome , 2010, PloS one.

[39]  Yan Ao,et al.  Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice , 2014, Nature Neuroscience.

[40]  Mark T. Harnett,et al.  An optimized fluorescent probe for visualizing glutamate neurotransmission , 2013, Nature Methods.

[41]  Yan Liu,et al.  Specification of transplantable astroglial subtypes from human pluripotent stem cells , 2011, Nature Biotechnology.

[42]  Yue Wang,et al.  FASP: A machine learning approach to functional astrocyte phenotyping from time-lapse calcium imaging data , 2016, 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI).

[43]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[44]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[45]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[46]  R. Folkerth,et al.  Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. , 2008, Human molecular genetics.

[47]  Baljit S. Khakh,et al.  TRPA1 channels regulate astrocyte resting calcium levels and inhibitory synapse efficacy via GAT-3 , 2011, Nature Neuroscience.

[48]  S. Antonarakis,et al.  Brief Report: Isogenic Induced Pluripotent Stem Cell Lines From an Adult With Mosaic Down Syndrome Model Accelerated Neuronal Ageing and Neurodegeneration , 2015, Stem cells.

[49]  Caine W. Wong,et al.  Altered Metabolism of the Amyloid β Precursor Protein Is Associated with Mitochondrial Dysfunction in Down's Syndrome , 2002, Neuron.

[50]  J. Nacher,et al.  Astrocytes of the murine model for Down Syndrome Ts65Dn display reduced intracellular ionic zinc , 2014, Neurochemistry International.

[51]  David H Rowitch,et al.  Astrocytes and disease: a neurodevelopmental perspective. , 2012, Genes & development.

[52]  Jason P. Weick,et al.  Deficits in human trisomy 21 iPSCs and neurons , 2013, Proceedings of the National Academy of Sciences.

[53]  Stefan R. Pulver,et al.  Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.

[54]  Marco Foddis,et al.  Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model , 2014, Nature Communications.

[55]  K. Gardiner,et al.  Down Syndrome: Genes, Model Systems, and Progress towards Pharmacotherapies and Clinical Trials for Cognitive Deficits , 2013, Cytogenetic and Genome Research.

[56]  Nachvak S.M,et al.  MITOCHONDRIAL DYSFUNCTION IN DOWN'S SYNDROME , 2005 .

[57]  F. Gage,et al.  Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. , 2008, Cell stem cell.

[58]  E. Shigetomi,et al.  Genetically Encoded Calcium Indicators and Astrocyte Calcium Microdomains , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[59]  M. Kawamura,et al.  Long-term facilitation of spontaneous calcium oscillations in astrocytes with endogenous adenosine in hippocampal slice cultures. , 2011, Cell calcium.